Sofinnova Partners raises €1.2 billion to fuel the next wave of life sciences innovation
Leading European venture capital firm exceeds €4 billion in assets under management, doubling its AUM in the last five years
PARIS, France – March 4, 2025 — Sofinnova Partners (“Sofinnova”), a leading European venture capital firm in life sciences based in Paris, London, and Milan, today announced it had raised €1.2 billion across its platform of investment strategies over the past year, including more than €1 billion secured in the last quarter. This achievement brings the firm’s assets under management (AUM) to more than €4 billion, solidifying its position as a leading backer of transformative innovation in healthcare and sustainability. Further details on individual funds will be disclosed upon their final closings.
